CORC  > 中国医学科学院 北京协和医学院
A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity
Chong Huihui; Xue Jing; Xiong Shengwen; Cong Zhe; Ding Xiaohui; Zhu Yuanmei; Liu Zixuan; Chen Ting; Feng Yifan; He Lei
2017
卷号91期号:11
关键词HIV-1 HIV-2 fusion inhibitor lipopeptide
ISSN号0022-538X
DOI10.1128/JVI.00288-17
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6367779
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Chong Huihui,Xue Jing,Xiong Shengwen,et al. A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity[J],2017,91(11).
APA Chong Huihui.,Xue Jing.,Xiong Shengwen.,Cong Zhe.,Ding Xiaohui.,...&He Yuxian.(2017).A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity.,91(11).
MLA Chong Huihui,et al."A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity".91.11(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace